nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Clotting—Octreotide—thymus cancer	0.0424	0.0424	CcSEcCtD
Temozolomide—Haemorrhoids—Octreotide—thymus cancer	0.0257	0.0257	CcSEcCtD
Temozolomide—Influenza-like symptoms—Octreotide—thymus cancer	0.0212	0.0212	CcSEcCtD
Temozolomide—Herpes zoster—Octreotide—thymus cancer	0.0201	0.0201	CcSEcCtD
Temozolomide—Cholestasis—Octreotide—thymus cancer	0.0199	0.0199	CcSEcCtD
Temozolomide—Otitis media—Octreotide—thymus cancer	0.0194	0.0194	CcSEcCtD
Temozolomide—Coagulopathy—Octreotide—thymus cancer	0.0194	0.0194	CcSEcCtD
Temozolomide—Petechiae—Octreotide—thymus cancer	0.0184	0.0184	CcSEcCtD
Temozolomide—Endocrine disorder—Octreotide—thymus cancer	0.0183	0.0183	CcSEcCtD
Temozolomide—Breast pain—Octreotide—thymus cancer	0.0173	0.0173	CcSEcCtD
Temozolomide—Amenorrhoea—Octreotide—thymus cancer	0.0172	0.0172	CcSEcCtD
Temozolomide—Viral infection—Octreotide—thymus cancer	0.0168	0.0168	CcSEcCtD
Temozolomide—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0166	0.0166	CcSEcCtD
Temozolomide—Herpes simplex—Octreotide—thymus cancer	0.0164	0.0164	CcSEcCtD
Temozolomide—Hearing impaired—Octreotide—thymus cancer	0.0159	0.0159	CcSEcCtD
Temozolomide—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Temozolomide—Vaginal inflammation—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Temozolomide—Influenza like illness—Octreotide—thymus cancer	0.0147	0.0147	CcSEcCtD
Temozolomide—Candida infection—Octreotide—thymus cancer	0.0145	0.0145	CcSEcCtD
Temozolomide—Vaginal infection—Octreotide—thymus cancer	0.0143	0.0143	CcSEcCtD
Temozolomide—Neuropathy—Octreotide—thymus cancer	0.0142	0.0142	CcSEcCtD
Temozolomide—Thrombophlebitis—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Temozolomide—Gastroenteritis—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Temozolomide—Deafness—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Temozolomide—Nasal congestion—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Temozolomide—Hot flush—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Temozolomide—Amnesia—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Temozolomide—Menopausal symptoms—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Temozolomide—Dehydration—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Temozolomide—Dry skin—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Temozolomide—Muscular weakness—Octreotide—thymus cancer	0.00969	0.00969	CcSEcCtD
Temozolomide—Abdominal distension—Octreotide—thymus cancer	0.00956	0.00956	CcSEcCtD
Temozolomide—Sweating increased—Octreotide—thymus cancer	0.00925	0.00925	CcSEcCtD
Temozolomide—Bronchitis—Octreotide—thymus cancer	0.00913	0.00913	CcSEcCtD
Temozolomide—Dysuria—Octreotide—thymus cancer	0.00888	0.00888	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Octreotide—thymus cancer	0.00883	0.00883	CcSEcCtD
Temozolomide—Pollakiuria—Octreotide—thymus cancer	0.00877	0.00877	CcSEcCtD
Temozolomide—Weight increased—Octreotide—thymus cancer	0.00864	0.00864	CcSEcCtD
Temozolomide—Weight decreased—Octreotide—thymus cancer	0.00859	0.00859	CcSEcCtD
Temozolomide—Hyperglycaemia—Octreotide—thymus cancer	0.00857	0.00857	CcSEcCtD
Temozolomide—Pneumonia—Octreotide—thymus cancer	0.00852	0.00852	CcSEcCtD
Temozolomide—Depression—Octreotide—thymus cancer	0.00844	0.00844	CcSEcCtD
Temozolomide—Neuropathy peripheral—Octreotide—thymus cancer	0.0083	0.0083	CcSEcCtD
Temozolomide—Urinary tract infection—Octreotide—thymus cancer	0.00823	0.00823	CcSEcCtD
Temozolomide—Hepatobiliary disease—Octreotide—thymus cancer	0.00801	0.00801	CcSEcCtD
Temozolomide—Sinusitis—Octreotide—thymus cancer	0.00794	0.00794	CcSEcCtD
Temozolomide—Hepatitis—Octreotide—thymus cancer	0.0076	0.0076	CcSEcCtD
Temozolomide—Hypoaesthesia—Octreotide—thymus cancer	0.00756	0.00756	CcSEcCtD
Temozolomide—Pharyngitis—Octreotide—thymus cancer	0.00754	0.00754	CcSEcCtD
Temozolomide—Oedema peripheral—Octreotide—thymus cancer	0.00749	0.00749	CcSEcCtD
Temozolomide—Visual impairment—Octreotide—thymus cancer	0.00733	0.00733	CcSEcCtD
Temozolomide—Tinnitus—Octreotide—thymus cancer	0.00709	0.00709	CcSEcCtD
Temozolomide—Flushing—Octreotide—thymus cancer	0.00705	0.00705	CcSEcCtD
Temozolomide—Cardiac disorder—Octreotide—thymus cancer	0.00705	0.00705	CcSEcCtD
Temozolomide—Immune system disorder—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Temozolomide—Alopecia—Octreotide—thymus cancer	0.00672	0.00672	CcSEcCtD
Temozolomide—Mental disorder—Octreotide—thymus cancer	0.00666	0.00666	CcSEcCtD
Temozolomide—Erythema—Octreotide—thymus cancer	0.00662	0.00662	CcSEcCtD
Temozolomide—Malnutrition—Octreotide—thymus cancer	0.00662	0.00662	CcSEcCtD
Temozolomide—Back pain—Octreotide—thymus cancer	0.0064	0.0064	CcSEcCtD
Temozolomide—Vision blurred—Octreotide—thymus cancer	0.00624	0.00624	CcSEcCtD
Temozolomide—Tremor—Octreotide—thymus cancer	0.0062	0.0062	CcSEcCtD
Temozolomide—Ill-defined disorder—Octreotide—thymus cancer	0.00614	0.00614	CcSEcCtD
Temozolomide—Anaemia—Octreotide—thymus cancer	0.00612	0.00612	CcSEcCtD
Temozolomide—Agitation—Octreotide—thymus cancer	0.00608	0.00608	CcSEcCtD
Temozolomide—Malaise—Octreotide—thymus cancer	0.00597	0.00597	CcSEcCtD
Temozolomide—Vertigo—Octreotide—thymus cancer	0.00594	0.00594	CcSEcCtD
Temozolomide—Palpitations—Octreotide—thymus cancer	0.00585	0.00585	CcSEcCtD
Temozolomide—Cough—Octreotide—thymus cancer	0.00577	0.00577	CcSEcCtD
Temozolomide—Convulsion—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Temozolomide—Hypertension—Octreotide—thymus cancer	0.00571	0.00571	CcSEcCtD
Temozolomide—Arthralgia—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Temozolomide—Myalgia—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Temozolomide—Anxiety—Octreotide—thymus cancer	0.00561	0.00561	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00559	0.00559	CcSEcCtD
Temozolomide—Discomfort—Octreotide—thymus cancer	0.00557	0.00557	CcSEcCtD
Temozolomide—Dry mouth—Octreotide—thymus cancer	0.00551	0.00551	CcSEcCtD
Temozolomide—Oedema—Octreotide—thymus cancer	0.0054	0.0054	CcSEcCtD
Temozolomide—Anaphylactic shock—Octreotide—thymus cancer	0.0054	0.0054	CcSEcCtD
Temozolomide—Infection—Octreotide—thymus cancer	0.00537	0.00537	CcSEcCtD
Temozolomide—Nervous system disorder—Octreotide—thymus cancer	0.0053	0.0053	CcSEcCtD
Temozolomide—Thrombocytopenia—Octreotide—thymus cancer	0.00529	0.00529	CcSEcCtD
Temozolomide—Skin disorder—Octreotide—thymus cancer	0.00525	0.00525	CcSEcCtD
Temozolomide—Hyperhidrosis—Octreotide—thymus cancer	0.00522	0.00522	CcSEcCtD
Temozolomide—Anorexia—Octreotide—thymus cancer	0.00515	0.00515	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00492	0.00492	CcSEcCtD
Temozolomide—Insomnia—Octreotide—thymus cancer	0.00488	0.00488	CcSEcCtD
Temozolomide—Paraesthesia—Octreotide—thymus cancer	0.00485	0.00485	CcSEcCtD
Temozolomide—Dyspnoea—Octreotide—thymus cancer	0.00481	0.00481	CcSEcCtD
Temozolomide—Somnolence—Octreotide—thymus cancer	0.0048	0.0048	CcSEcCtD
Temozolomide—Dyspepsia—Octreotide—thymus cancer	0.00475	0.00475	CcSEcCtD
Temozolomide—Decreased appetite—Octreotide—thymus cancer	0.00469	0.00469	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00466	0.00466	CcSEcCtD
Temozolomide—Fatigue—Octreotide—thymus cancer	0.00466	0.00466	CcSEcCtD
Temozolomide—Pain—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Temozolomide—Constipation—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Temozolomide—Feeling abnormal—Octreotide—thymus cancer	0.00445	0.00445	CcSEcCtD
Temozolomide—Gastrointestinal pain—Octreotide—thymus cancer	0.00442	0.00442	CcSEcCtD
Temozolomide—Urticaria—Octreotide—thymus cancer	0.00429	0.00429	CcSEcCtD
Temozolomide—Abdominal pain—Octreotide—thymus cancer	0.00427	0.00427	CcSEcCtD
Temozolomide—Body temperature increased—Octreotide—thymus cancer	0.00427	0.00427	CcSEcCtD
Temozolomide—Hypersensitivity—Octreotide—thymus cancer	0.00398	0.00398	CcSEcCtD
Temozolomide—Asthenia—Octreotide—thymus cancer	0.00387	0.00387	CcSEcCtD
Temozolomide—Pruritus—Octreotide—thymus cancer	0.00382	0.00382	CcSEcCtD
Temozolomide—Diarrhoea—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Temozolomide—Dizziness—Octreotide—thymus cancer	0.00357	0.00357	CcSEcCtD
Temozolomide—Vomiting—Octreotide—thymus cancer	0.00343	0.00343	CcSEcCtD
Temozolomide—Rash—Octreotide—thymus cancer	0.0034	0.0034	CcSEcCtD
Temozolomide—Dermatitis—Octreotide—thymus cancer	0.0034	0.0034	CcSEcCtD
Temozolomide—Headache—Octreotide—thymus cancer	0.00338	0.00338	CcSEcCtD
Temozolomide—Nausea—Octreotide—thymus cancer	0.00321	0.00321	CcSEcCtD
